AnnouncementsIntec Capital: Outcome of delisting committee meeting
AnnouncementsDynacons Technologies: Updates on open offer
AnnouncementsIntec Capital: Updates on delisting offer
AnnouncementsIndo-Asian Projects forfeits partly paid-up shares
AnnouncementsAshram Online.Com appoints D. Hemamalini as CFO
AnnouncementsCrompton Greaves: Updates on outcome of AGM
AnnouncementsKushal Tradelink: Outcome of AGM
AnnouncementsBajaj Finserv: Updates on outcome of AGM
100% of moneycontrol users recommend buying Glenmark.
What's your call on Glenmark today?
Read 5 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2826.25||-0.43||2939.80||2128.40||48,140.94|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Sical Logistics Recommended on Jun 2nd 2014
Recommended price 85.00 | Peak from reco 129.40 53.14%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 19,508.60 crore.The company has reported a consolidated sales of Rs 1,477.82 crore and a Net Profit of Rs 184.90 crore for the quarter ended Jun 2014.
The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh V Desai - Executive Director & CFO, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, Bernard Munos - Non Executive Director, J F Ribeiro - Non Executive Director, Brian W Tempest - Non Executive Director, Sridhar Gorthi - Non Executive Director, Hocine Sidi Said - Non Executive Director, N B Desai - Non Executive Director.
It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.
Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.
Their Registrars are Karvy Computershare Private Ltd.